# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001171843-15-002167
Filing Date
2015-04-24
Accepted
2015-04-24 11:48:03
Documents
5
Effectiveness Date
2015-04-24

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE ADDITIONAL MATERIALS | defa14a_042315.htm | DEFA14A | 25820
2 |  | nacard_1.jpg | GRAPHIC | 174634
3 |  | nacard_2.jpg | GRAPHIC | 295604
4 |  | nacard_3.jpg | GRAPHIC | 128971
5 |  | nacard_4.jpg | GRAPHIC | 23240
| Complete submission text file | 0001171843-15-002167.txt |  | 885069

Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14027 | Film No.: 15790680
SIC: 3841 Surgical & Medical Instruments & Apparatus